Agilent Technologies Inc. Joins Forces With Baylor College of Medicine To Provide Customized CGH Microarrays For Cancer, Prenatal And Postnatal Research

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has announced it is collaborating with Baylor College of Medicine’s Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor’s data-rich expertise in genetics research with Agilent’s microarray manufacturing capabilities to enable advanced discoveries in cancer and cytogenetics research. The collaboration announcement was delivered at the American Society of Human Genetics conference in Boston last month.

Help employers find you! Check out all the jobs and post your resume.